Zeng et al. performed a meta-analysis of prospective studies and provided evidence that elevated levels of CRP are associated with an increased risk of ovarian cancer, while levels of circulating Il-6, TNFα and soluble TNFR2 are not [52]. Here, TNFRSF1B is linked to ovarian carcinoma.